Ilana Cohen

Title: Ilana Cohen: Innovator in Protein Kinase Inhibitors

Introduction

Ilana Cohen is a prominent inventor based in Nes Ziona, Israel. She has made significant contributions to the field of biochemistry, particularly in the development of protein kinase inhibitors. Her innovative work focuses on creating small molecules that can effectively target and inhibit specific protein kinases, which play crucial roles in various diseases.

Latest Patents

Ilana Cohen holds a patent for "Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics." This invention provides small molecules with high affinity for the ATP binding site of protein kinases. These molecules are conjugated to a peptide or peptidomimetic moiety that mimics the substrate of PKB. The chimeric compounds serve as PKB inhibitors with improved activity and selectivity. The novel ATP mimetic compounds, particularly isoquinoline derivatives, are useful as inhibitors of protein kinases for experimental, medical, and drug design purposes. Additionally, pharmaceutical compositions comprising these protein kinase inhibitors are disclosed for the treatment and diagnosis of various conditions, including cancers, diabetes, cardiovascular pathologies, and autoimmune diseases.

Career Highlights

Ilana Cohen is associated with Curegenics Ltd., where she continues to advance her research and development efforts. Her work has garnered attention for its potential applications in medical treatments and drug design.

Collaborations

Ilana collaborates with notable colleagues, including Nurit Livnah and Tamar Yechezkel. Their combined expertise contributes to the innovative research being conducted at Curegenics Ltd.

Conclusion

Ilana Cohen's contributions to the field of protein kinase inhibitors highlight her role as a leading inventor in biochemistry. Her innovative approaches have the potential to impact the treatment of various diseases significantly.